Director, Access Strategy & Marketing
Revolution Medicines - Remote (United States)
Posted Oct 27, 2026
Benefits
- Parental leave
- Not verified
- Non-birth-parent leave
- Not verified
- Family-building benefits
-
- Fertility benefits: Not verified
- Adoption assistance: Not verified
- Surrogacy assistance: Not verified
- Mental health support
- Not verified
- Relocation assistance
- Not verified
- Childcare support
- Not verified
- Learning budget
- Not verified
- Verification
- Not verified checked Nov 20, 2026
- Salary
- $201K-$251K From the posting source checked Nov 16, 2026
- 401(k) match
- Reported from DOL Form 5500 industry filing (not employer-specific)
Was this benefit information wrong? Tell us.
Market context
- U.S. role benchmark (BLS OEWS)
- $93,011 U.S. median for this role
- Projected growth (BLS Employment Projections)
- +5.1% - Faster than average
143% above the BLS role benchmark for marketing aggregate.
Matched to SOC 13-1161 - Marketing aggregate by role bucket.
Source:U.S. Bureau of Labor Statistics, OEWS, May 2024andEmployment Projections, 2024-2034.
Role
Schedule
- Shift type
- Not verified
- Weekend work
- Not verified
Company
- Equity
- Offered Verified - SEC 10-K source checked Nov 16, 2026
Application
- Cover letter
- Not verified
- Assessment
- Not verified
- Deadline
- Not stated
Where they hire
State eligibility is not yet verified.
About this role
Director, Access Strategy & Marketing Remote (United States) Revolution Medicines is a global, commercial-state oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers. Leveraging its differentiated RAS(ON) tri-complex inhibitor platform, the company is advancing a broad, integrated portfolio of oral RAS(ON) inhibitors designed to directly target the active, cancer-driving state of RAS. Founded on rigorous scientific inquiry and a willingness to challenge long-held assumptions, Revolution Medicines is committed to changing the trajectory of disease for patients with RAS-addicted cancers worldwide. Our people are united by a shared way of working: follow the science, challenge assumptions, act with urgency and hold ourselves to a high standard of rigor-all in service of patients. The Opportunity: The Director of Access Strategy & Marketing will lead the development and execution of access strategies, non-clinical positioning, and marketing materials for the RevMed portfolio with a focus on pancreatic adenocarcinoma (PDAC) or non-small cell lung cancer (NSCLC). This role will focus on developing the short to medium term non-clinical value proposition across payers, HCPs, organized customers (GPOs, IDNs, etc.) and channel partners. This role will be instrumental in supporting a successful launch through strategy and tactical planning, tailoring messages to various customer types, and working cross-functionally with Brand Marketing, National Account, Medical/HEOR, Regulatory and Compliance partners. The ideal candidate will have exceptional strategy, influence, and collaboration competencies, oncology launch experience, and experience translating a dynamic landscape into access strategy. This position is open to remote candidates, though preference will be
Read the full description at www.revmed.com. FewerJobs shows a preview and links to the original posting.
Apply link verified; last checked Nov 20, 2026.
What verified means
Verified means a displayed claim has field-level provenance to a source FewerJobs pulled: a government or employer source, or the original job posting. Posting-sourced facts are employer-stated and are labeled separately from government records.
Related jobs
Associate Director, Access Strategy and Marketing
Revolution Medicines - Remote (United States)
Director, Access Marketing
Amylyx Pharmaceuticals Inc - Cambridge, MA
Director Global Oncology Marketing, Early Commercial Team
Merck & Co., Inc. - USA - New Jersey - Rahway
Director - Integrated and Field Marketing
Veeva - Massachusetts - Boston